A microfluidics platform for combinatorial drug screening on cancer biopsies
Cancer patients exhibit specific sensitivities toward drug combinations that cannot be easily predicted. Here the authors setup a microfluidic platform that allows testing of multiple drug combinations correctly predicting sensitivity in vivo and they use it on patients biopsies to define effective...
Guardado en:
Autores principales: | Federica Eduati, Ramesh Utharala, Dharanija Madhavan, Ulf Peter Neumann, Thomas Longerich, Thorsten Cramer, Julio Saez-Rodriguez, Christoph A. Merten |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b6bc84e761d240379ee00dadd6ae25c4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Droplet-based microfluidic platform for high-throughput screening of Streptomyces
por: Ran Tu, et al.
Publicado: (2021) -
Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response
por: Tudor Petreus, et al.
Publicado: (2021) -
Precision cell-free DNA extraction for liquid biopsy by integrated microfluidics
por: Hoyoon Lee, et al.
Publicado: (2020) -
Efficient molecular evolution to generate enantioselective enzymes using a dual-channel microfluidic droplet screening platform
por: Fuqiang Ma, et al.
Publicado: (2018) -
CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
por: Karol Szlachta, et al.
Publicado: (2018)